EDGAR Filing Documents for 0001144204-13-036025

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001144204-13-036025

Filing Date

2013-06-21

Accepted

2013-06-21 13:08:29

Documents

Period of Report

2013-03-31

Document Format Files

Seq	Description	Document	Type	Size
1	ANNUAL REPORT	v346280_10k.htm	10-K	1207652
2	EXHIBIT 21	v346280_ex21.htm	EX-21	1457
3	EXHIBIT 23	v346280_ex23.htm	EX-23	3135
4	EXHIBIT 31.1	v346280_ex31-1.htm	EX-31.1	9061
5	EXHIBIT 31.2	v346280_ex31-2.htm	EX-31.2	9039
6	EXHIBIT 32.1	v346280_ex32-1.htm	EX-32.1	4470
7	EXHIBIT 32.2	v346280_ex32-2.htm	EX-32.2	4678
	Complete submission text file	0001144204-13-036025.txt		8558559

Data Files

Seq	Description	Document	Type	Size
8	XBRL INSTANCE DOCUMENT	eltp-20130331.xml	EX-101.INS	1342207
9	XBRL TAXONOMY EXTENSION SCHEMA	eltp-20130331.xsd	EX-101.SCH	77946
10	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	eltp-20130331_cal.xml	EX-101.CAL	37254
11	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	eltp-20130331_def.xml	EX-101.DEF	326733
12	XBRL TAXONOMY EXTENSION LABEL LINKBASE	eltp-20130331_lab.xml	EX-101.LAB	498005
13	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	eltp-20130331_pre.xml	EX-101.PRE	422690

Mailing Address 165 LUDLOW AVENUE NORTHVALE NJ 07647

Business Address 165 LUDLOW AVENUE NORTHVALE NJ 07647 2017502646

ELITE PHARMACEUTICALS INC /NV/ (Filer) CIK: 0001053369 (see all company filings)